Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank80
3Y CAGR+36.1%
5Y CAGR+72.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+36.1%/yr
vs +58.2%/yr prior
5Y CAGR
+72.8%/yr
Recent deceleration
Acceleration
-22.2pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
15.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.74M | -29.4% |
| 2024 | $3.88M | +25.0% |
| 2023 | $3.10M | +185.4% |
| 2022 | $1.09M | +472.1% |
| 2021 | $190000.00 | +6.7% |
| 2020 | $178000.00 | +3.3% |
| 2019 | $172393.00 | -0.6% |
| 2018 | $173359.00 | -44.0% |
| 2017 | $309553.00 | -87.7% |
| 2016 | $2.53M | - |